📰 Aktx News
Aktx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aktx. Real-time updates on events, politics, business and more.
May 6, 2024
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance AKTX opened at $1.36 on Thursday. The stock’s 50 day moving average price is $1.69 and its 200-day moving average price is […]
April 20, 2024
StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report report published on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX stock opened at $1.17 on Tuesday. Akari Therapeutics has a 1 year low of $1.08 and a 1 […]
April 12, 2024
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 10,500 shares, an increase of 75.0% from the March 15th total of 6,000 shares. Approximately 0.2% of the shares of the stock are […]
March 26, 2024
StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 4.4 % Shares of NASDAQ AKTX opened at $1.89 on Friday. Akari Therapeutics has a 1 year low of $1.66 and a […]
February 13, 2024
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 1,900 shares, a decline of 66.7% from the January 15th total of 5,700 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average […]
January 21, 2024
Stock analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Down 13.6 % NASDAQ:AKTX opened at $2.60 on Friday. The company’s 50 day moving average price is $3.01 and […]
December 30, 2023
Akari Therapeutics, Plc (NASDAQ:AKTX – Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 1,700 shares, a decrease of 50.0% from the November 30th total of 3,400 shares. Based on an average daily volume of 12,000 shares, the days-to-cover ratio is currently 0.1 […]
December 21, 2023
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of Akari Therapeutics stock opened at $2.96 on Monday. The stock has a 50-day moving average price of $3.26 and […]
December 19, 2023
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 1.4 % Shares of NASDAQ:AKTX opened at $2.84 on Monday. Akari Therapeutics has a 1 year low of […]
November 28, 2023
StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of AKTX stock opened at $2.91 on Friday. The firm has a fifty day simple moving average of $3.51 and […]